Management of iron deficiency anemia in pregnancy: a cross-sectional survey on iron formulations and taurine perception

Background: Iron deficiency anemia (IDA) is a widespread health concern with multiple treatment options, yet obstetrician gynecologist preferences and clinical outcomes vary considerably. Taurine is gaining attention as a potential adjunct due to its role in erythropoiesis and antioxidant effects. Methods: Cross sectional survey was conducted among 197 practicing obstetricians and gynecologists in India. A structured 9 item questionnaire assessed iron salt preferences, side effect experiences, perceptions of tablet size and patient compliance, and views on prescribing taurine containing iron supplements. Data were analyzed using descriptive statistics. Results: Ferrous ascorbate was the preferred iron salt for 98.47% of obstetrician gynecologist, with 84.77% reporting minimal side effects. Tablet size was deemed important for compliance by 97.46% of respondents. A total of 91.87% favored prescribing taurine enriched formulations for fetal wellbeing, and 91.37% had previously prescribed R. B. Tone Rapid. Moreover, after 8 weeks of ferrous ascorbate therapy in IDA, a 25% rise in hemoglobin from baseline was the most commonly expected outcome (57.86%), followed by 50% (26.40%) and 40% (15.73%). R. B. Tone Rapid was preferred in cases of IDA (81.21%), fetal growth restriction (26.9%), and maternal obesity (28.42%). Additionally, majority of Obstetricians and Gynecologists (63.96%) recommended organizing a hemoglobin detection camp at their clinic. Conclusions: Obstetrician gynecologist demonstrated a strong preference for ferrous ascorbate and expressed confidence in taurine containing iron therapies. The findings support a shift toward better tolerated, functionally enhanced supplements in pregnancy related IDA. Further research is needed to validate these perceptions and inform treatment guidelines.